Trial Design Solutions

1. Drug Development Experience For Biotechs 8/8/2024

   Leverage our extensive expertise across over 120 therapeutic indications to drive your success.

2. Why Australia Is The Best Place In The World For Early Phase Studies 8/8/2024

   The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.

3. Only Elligo Mitigates Research Risk 4/18/2023

   Uncertainty is inherent in clinical research. Uncover new strategies and solutions to alleviate risk so clinical teams can confidently and quickly bring products to market.

4. IRB Services For Institutional Sites 3/2/2023

   Advarra can serve as your partner for everything from single investigational sites to multisite research consortia and therapeutic networks.

5. The #1 Rated Leader In DCT Now Offers The Vaccine Pathway 6/17/2022

   Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.

6. Supporting Your Complex Immuno-Oncology Trials 3/4/2021

   IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans across multiple treatment modalities (vaccines, bispecific antibodies, adoptive cell therapies [ACT], etc.) and numerous indications across hematologic malignancies and solid tumors.

7. Phlexglobal Experts Fill The Gaps In eTMF Management 12/16/2022

   Enable busy study teams to assess, prevent, and manage risk across the entire TMF spectrum – improving inspection-readiness with less effort.

8. Integrated Programs To Bridge Molecules From Discovery Into Clinical Development 1/4/2023

   A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.

9. Nurturing Advanced Therapies For Neurology, Psychiatry, And Pain 8/8/2023

   Explore how Signent's offerings aid CNS research teams in enhancing the efficiency, effectiveness, and global impact of their studies, for the benefit of all participants involved.

10. Isotope Labelling 3/3/2022

    Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.